AdaptHealth [AHCO] vs Artivion [AORT] Detailed Stock Comparison
AdaptHealth
NASDAQ
Loading...
Artivion
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: AdaptHealth wins in 13 metrics, Artivion wins in 6 metrics, with 0 ties. AdaptHealth appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | AdaptHealth | Artivion | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.83 | -128.28 | Artivion |
| Price-to-Book Ratio | 0.76 | 4.61 | AdaptHealth |
| Debt-to-Equity Ratio | 122.33 | 62.81 | Artivion |
| PEG Ratio | -0.73 | 0.80 | AdaptHealth |
| EV/EBITDA | 4.89 | 47.17 | AdaptHealth |
| Profit Margin (TTM) | 2.49% | -4.43% | AdaptHealth |
| Operating Margin (TTM) | 7.10% | 9.72% | Artivion |
| EBITDA Margin (TTM) | 7.10% | 9.72% | Artivion |
| Return on Equity | 5.51% | -5.02% | AdaptHealth |
| Return on Assets (TTM) | 3.70% | 1.70% | AdaptHealth |
| Free Cash Flow (TTM) | $235.78M | $11.05M | AdaptHealth |
| 1-Year Return | -11.20% | 57.21% | Artivion |
| Price-to-Sales Ratio (TTM) | 0.38 | 4.78 | AdaptHealth |
| Enterprise Value | $3.09B | $2.15B | AdaptHealth |
| EV/Revenue Ratio | 0.95 | 5.30 | AdaptHealth |
| Gross Profit Margin (TTM) | -9.11% | 64.72% | Artivion |
| Revenue per Share (TTM) | $24 | $10 | AdaptHealth |
| Earnings per Share (Diluted) | $0.54 | $-0.43 | AdaptHealth |
| Beta (Stock Volatility) | 1.62 | 1.67 | AdaptHealth |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
AdaptHealth vs Artivion Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| AdaptHealth | -1.43% | 3.23% | -4.88% | -3.14% | -6.28% | -7.63% |
| Artivion | -0.73% | -3.07% | -6.19% | 34.53% | 76.48% | 45.12% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| AdaptHealth | -11.20% | -56.65% | -68.16% | -7.63% | -7.63% | -7.63% |
| Artivion | 57.21% | 291.07% | 112.02% | 292.58% | 518.36% | 483.81% |
News Based Sentiment: AdaptHealth vs Artivion
AdaptHealth
News based Sentiment: MIXED
The month of October 2025 saw a surge in institutional investment in AdaptHealth, indicating growing confidence from major players. However, this positive trend is offset by an insider sale and conflicting analyst ratings, creating a mixed investment narrative. The overall significance is high due to the substantial capital inflows.
Artivion
News based Sentiment: MIXED
October was a mixed month for Artivion, with a significant earnings beat and positive analyst revisions offset by notable insider selling and fluctuating stock performance. The combination of positive financial results and concerning insider activity creates a complex investment narrative, making it a moderately important month for investors.
Performance & Financial Health Analysis: AdaptHealth vs Artivion
| Metric | AHCO | AORT |
|---|---|---|
| Market Information | ||
| Market Cap | $1.26B | $1.98B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 914,870 | 388,190 |
| 90 Day Avg. Volume | 1,022,170 | 443,357 |
| Last Close | $8.96 | $40.75 |
| 52 Week Range | $7.11 - $11.63 | $21.97 - $45.07 |
| % from 52W High | -22.96% | -9.59% |
| All-Time High | $41.58 (Feb 01, 2021) | $45.07 (Aug 22, 2025) |
| % from All-Time High | -78.45% | -9.59% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.15% |
| Quarterly Earnings Growth | -0.25% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | -0.04% |
| Operating Margin (TTM) | 0.07% | 0.10% |
| Return on Equity (TTM) | 0.06% | -0.05% |
| Debt to Equity (MRQ) | 122.33 | 62.81 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $12.00 | $8.91 |
| Cash per Share (MRQ) | $0.53 | $1.13 |
| Operating Cash Flow (TTM) | $552.34M | $19.65M |
| Levered Free Cash Flow (TTM) | $235.10M | $-12,697,875 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: AdaptHealth vs Artivion
| Metric | AHCO | AORT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.83 | -128.28 |
| Forward P/E | 10.69 | 171.04 |
| PEG Ratio | -0.73 | 0.80 |
| Price to Sales (TTM) | 0.38 | 4.78 |
| Price to Book (MRQ) | 0.76 | 4.61 |
| Market Capitalization | ||
| Market Capitalization | $1.26B | $1.98B |
| Enterprise Value | $3.09B | $2.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.95 | 5.30 |
| Enterprise to EBITDA | 4.89 | 47.17 |
| Risk & Other Metrics | ||
| Beta | 1.62 | 1.67 |
| Book Value per Share (MRQ) | $12.00 | $8.91 |
Financial Statements Comparison: AdaptHealth vs Artivion
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AHCO | AORT |
|---|---|---|
| Revenue/Sales | $580.47M | $112.97M |
| Cost of Goods Sold | $657.44M | $39.86M |
| Gross Profit | $-76.97M | $73.11M |
| Research & Development | N/A | $7.06M |
| Operating Income (EBIT) | $23.17M | $8.38M |
| EBITDA | $117.52M | $18.95M |
| Pre-Tax Income | $-5.23M | $3.48M |
| Income Tax | $850,000 | $2.14M |
| Net Income (Profit) | $-6.08M | $1.35M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AHCO | AORT |
|---|---|---|
| Cash & Equivalents | $53.65M | $37.69M |
| Total Current Assets | $745.17M | $287.30M |
| Total Current Liabilities | $576.73M | $51.94M |
| Long-Term Debt | $2.04B | $356.98M |
| Total Shareholders Equity | $1.57B | $294.25M |
| Retained Earnings | $-569.39M | $-61.77M |
| Property, Plant & Equipment | $1.03B | $77.04M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AHCO | AORT |
|---|---|---|
| Operating Cash Flow | $95.33M | $-17.94M |
| Capital Expenditures | $-95.59M | N/A |
| Free Cash Flow | $-58,000 | $-20.59M |
| Debt Repayment | $-28.22M | $-66,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AHCO | AORT |
|---|---|---|
| Shares Short | 10.40M | 1.08M |
| Short Ratio | 11.51 | 2.52 |
| Short % of Float | 0.10% | 0.03% |
| Average Daily Volume (10 Day) | 914,870 | 388,190 |
| Average Daily Volume (90 Day) | 1,022,170 | 443,357 |
| Shares Outstanding | 134.60M | 41.95M |
| Float Shares | 89.45M | 41.61M |
| % Held by Insiders | 0.08% | 0.05% |
| % Held by Institutions | 1.04% | 0.90% |
Dividend Analysis & Yield Comparison: AdaptHealth vs Artivion
| Metric | AHCO | AORT |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |